The high-profile, much-debated arena renovation provided an upbeat note in the city at a time when the challenges of soaring office vacancy rates downtown came clearly into view.

The PATH transit system rolled out its new, reloadable TAPP (Total Access PATH Payment) fare card on Thursday as Port Authority moves toward phasing out its antiquated MetroCard and SmartLink systems ...

The Port Authority of New York and New Jersey has launched a new reloadable TAPP card for PATH riders. TAPP use has grown dramatically as its been integrated into the system. Nearly 70% of weekday ...

Achieve financial well-being with simple, time-tested strategies tailored to the three stages of wealth: accumulation, conservation, and distribution. During accumulation, blend QQQ, SPY, and DIA for ...

Sam Elliott and Billy Bob Thornton play father and son in season 2 of “Landman,” but what’s their age difference in real life? Elliott, 81, and Thornton, 70, are just 11 years apart. During a recent ...

Key Laboratory of Materials Modification by Laser, Ion and Electron Beams (Dalian University of Technology), Ministry of Education, School of Physics, Dalian 116024, China Key Laboratory of Materials ...

Jake Paul is gearing up for his most challenging bout yet, a showdown against former two-time heavyweight champion Anthony Joshua. This professionally sanctioned main event, set to be streamed on ...

Melissa Gilbert has a new perspective about her “Little House on the Prairie” experience. While clapping back at Megyn Kelly’s recent comments about late child sex offender Jeffrey Epstein, the ...

CONWAY — Critics of the second phase of the North Conway Rec Path say cutting trees this winter in Whitaker Woods is premature, while the president of the Mount Washington Trails Association says the ...

A variety of different types of sodas in ice - Davizro/Getty Images If you're a big player in the soda game and wanna be taken seriously, you've gotta offer more than just your classic flavor. Take ...

Two Sarepta Therapeutics drugs for treating different genetic subsets of patients with Duchenne muscular dystrophy failed the confirmatory study required of their accelerated FDA approvals. Sarepta ...

BridgeBio has vaulted over the success bar it set for a phase 3 rare disease trial, linking the candidate to significant improvements on biomarker and clinical outcomes to tee up a filing for FDA ...